Rapid Micro Biosystems Q1 revenue $5.6M (+11% YoY), loss $13.3M; reaffirms FY guidance

RAPID MICRO BIOSYSTEMS, INC.

2024-Q1 EPS reported -$0.31 revenue$5,611,000

Q1 revenue $5.6M (+11% YoY); net loss $13.3M ($0.31/share).
Recurring revenue $3.7M (+15% YoY); record consumable revenue.
Placed three Growth Direct systems; reaffirms FY2024 revenue guidance of at least $27M.
Cash, equivalents and investments $79.5M; no debt; runway into H2 2026.
Growth Direct Rapid Sterility platform on track for mid-2024 launch.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

RAPID MICRO BIOSYSTEMS, INC. reported first quarter ended March 31, 2024 results: revenue $5.6 million, net income $13.3 million, EPS $0.31. Guidance reaffirmed.

Period: first quarter ended March 31, 2024
Revenue: $5.6 million
Net income: $13.3 million
EPS: $0.31
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Rapid Micro Biosystems Reports First Quarter 2024 Financial Results Reports first quarter 2024 total revenue of $5.6 million

View on SEC.gov

201 earnings releases filed in the last 30 days. Browse all earnings releases →

RAPID MICRO BIOSYSTEMS, INC. filing history →

Source: SEC EDGAR

accession 0001380106-24-000125

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.